These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 195802)

  • 1. [Nuclear receptors for triiodothyronine. I. Binding of triiodothyronine (T-3) in rat liver following in vivo administration of labelled hormone].
    Kubica A; Nauman A; Witkowska E; Nauman J
    Endokrynol Pol; 1977; 28(3):207-14. PubMed ID: 195802
    [No Abstract]   [Full Text] [Related]  

  • 2. [Triiodothyronine binding by the liver nuclei and mitochondria].
    Rachev RR; Dimitrov MI; Filipova EKh; Dimitrov OA; Gaĭdarova KD
    Probl Endokrinol (Mosk); 1979; 25(6):60-5. PubMed ID: 230474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Triiodothyronine nuclear receptors. II. In vitro T-3 rat liver nuclear receptors interaction. Effect of age on kinetic parameters of binding].
    Kubica A; Nauman J
    Endokrynol Pol; 1977; 28(5):387-94. PubMed ID: 200417
    [No Abstract]   [Full Text] [Related]  

  • 4. Glucagon administration decreases hepatic nuclear triiodothyronine binding capacity.
    Dillmann WH; Bonner RA; Oppenheimer JH
    Endocrinology; 1978 May; 102(5):1633-6. PubMed ID: 217631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of divalent cations on the binding of 3,5,3'-triiodothyronine to isolated rat liver nuclei.
    Rodriguez-Peña A; Bernal J
    Endocrinology; 1982 Jan; 110(1):246-53. PubMed ID: 6274620
    [No Abstract]   [Full Text] [Related]  

  • 6. Nuclear receptors for 3,5,3'-triiodothyronine in human liver and kidney: characterization, quantitation, and similarities to rat receptors.
    Schuster LD; Schwartz HL; Oppenheimer JH
    J Clin Endocrinol Metab; 1979 Apr; 48(4):627-32. PubMed ID: 219002
    [No Abstract]   [Full Text] [Related]  

  • 7. Roentgenographic contrast agents inhibit triiodothyronine binding to nuclear receptors in vitro.
    DeGroot LJ; Rue PA
    J Clin Endocrinol Metab; 1979 Oct; 49(4):538-42. PubMed ID: 225345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of nuclear 5,5,3'-triiodothyronine-binding capacity and tissue response in the liver of the neonatal rat.
    Coulombe P; Ruel J; Dussault JH
    Endocrinology; 1979 Oct; 105(4):952-9. PubMed ID: 225160
    [No Abstract]   [Full Text] [Related]  

  • 9. Identical pattern of release of specific triiodothyronine receptors by micrococcal nuclease from rat cerebral cortex and liver nuclei.
    Silva JE
    Endocrinology; 1983 Aug; 113(2):699-705. PubMed ID: 6307648
    [No Abstract]   [Full Text] [Related]  

  • 10. Triiodothyronine nuclear receptor in chick embryo: nature and properties of hepatic receptor.
    Bellabarba D; Lehoux JG
    Endocrinology; 1981 Oct; 109(4):1017-25. PubMed ID: 6269827
    [No Abstract]   [Full Text] [Related]  

  • 11. Modulation of nuclear receptor affinity for 3,5,3'-triiodothyronine by nucleotide in vitro.
    Brtko J; Knopp J
    Endocrinol Exp; 1985 Dec; 19(4):245-51. PubMed ID: 3002752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability of nuclear triiodothyronine binding sites.
    Jaffe RC; Means AR
    Endocrinology; 1977 Aug; 101(2):447-52. PubMed ID: 195793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limitations in the conventional analysis of the interaction of triiodothyronine with solubilized nuclear receptor sites. Inapparent binding of triiodothyronine to nonspecific binding sites.
    Seelig S; Schwartz HL; Oppenheimer JH
    J Biol Chem; 1981 Mar; 256(5):2154-61. PubMed ID: 6257704
    [No Abstract]   [Full Text] [Related]  

  • 14. Nuclear triiodothyronine receptor sites in brain: probable identity with hepatic receptors and regional distribution.
    Schwartz HL; Oppenheimer JH
    Endocrinology; 1978 Jul; 103(1):267-73. PubMed ID: 217638
    [No Abstract]   [Full Text] [Related]  

  • 15. In vitro binding of L-triiodothyronine to receptors in rat liver nuclei. Kinectics of binding, extraction properties, and lack of requirement for cytosol proteins.
    Surks MI; Koerner DH; Oppenheimer JH
    J Clin Invest; 1975 Jan; 55(1):50-60. PubMed ID: 162784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Humoral modulation of hepatic nuclear triiodothyronine receptors in the cross-circulated rat.
    Short J; McDermott P; Truitte D
    Horm Metab Res; 1982 Apr; 14(4):224. PubMed ID: 6282730
    [No Abstract]   [Full Text] [Related]  

  • 17. Interaction of N-bromoalkyl derivatives of iodothyronines with the nuclear triiodothyronine receptor.
    Anselmet A; Torresani J
    Biochem Biophys Res Commun; 1981 Feb; 98(3):685-92. PubMed ID: 6261749
    [No Abstract]   [Full Text] [Related]  

  • 18. Thyroid hormone action: in vitro characterization of solubilized nuclear receptors from rat liver and cultured GH1 cells.
    Samuels HH; Tsai JS; Casanova J; Stanley F
    J Clin Invest; 1974 Oct; 54(4):853-65. PubMed ID: 4372251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversible dissociation of triiodothyronine-nuclear receptor complexes by mercurial and chaotropic reagents.
    Ferreira MM; Bismuth J; Torresani J
    Biochem Biophys Res Commun; 1982 Mar; 105(1):244-51. PubMed ID: 6284144
    [No Abstract]   [Full Text] [Related]  

  • 20. Contributions of plasma triiodothyronine and local thyroxine monodeiodination to triiodothyronine to nuclear triiodothyronine receptor saturation in pituitary, liver, and kidney of hypothyroid rats. Further evidence relating saturation of pituitary nuclear triiodothyronine receptors and the acute inhibition of thyroid-stimulating hormone release.
    Silva JE; Larsen PR
    J Clin Invest; 1978 May; 61(5):1247-59. PubMed ID: 207733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.